NATURETIN 5MG DIN 00029343
Status: Cancelled Post Market
Holder: SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC.
Molecule: BENDROFLUMETHIAZIDE
Health Canada record
| Active ingredient(s) | BENDROFLUMETHIAZIDE 5 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C03AA01 BENDROFLUMETHIAZIDE |
| Original market date | 31-Dec-1959 |
| Current status date | 07-Jan-1999 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
International API supply for BENDROFLUMETHIAZIDE
2 valid EDQM Certificates of Suitability from 2 holders. 1 active FDA Drug Master Files.
Request a quote for NATURETIN 5MG